{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:58:55Z","timestamp":1777409935158,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00277-024-06175-z","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T03:44:08Z","timestamp":1737085448000},"page":"1307-1315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Genetic alterations and their prognostic impact in marginal zone lymphoma: a meta-analysis"],"prefix":"10.1007","volume":"104","author":[{"given":"Xijing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licai","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"issue":"11","key":"6175_CR1","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/bjc.2011.450","volume":"105","author":"A Smith","year":"2011","unstructured":"Smith A et al (2011) Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer 105(11):1684\u20131692","journal-title":"Br J Cancer"},{"key":"6175_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcancer.2013.11.005","volume":"24","author":"C Thieblemont","year":"2014","unstructured":"Thieblemont C et al (2014) Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type. Sem Cancer Biol 24:33\u201342","journal-title":"Sem Cancer Biol"},{"issue":"18","key":"6175_CR3","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","volume":"21","author":"M Parry","year":"2015","unstructured":"Parry M et al (2015) Genetics and Prognostication in Splenic Marginal Zone lymphoma: revelations from deep sequencing. Clin Cancer Res 21(18):4174\u20134183","journal-title":"Clin Cancer Res"},{"issue":"3","key":"6175_CR4","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1182\/blood-2011-02-339556","volume":"119","author":"AJ Arribas","year":"2012","unstructured":"Arribas AJ et al (2012) Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets. Blood 119(3):e9\u2013e21","journal-title":"Blood"},{"issue":"10","key":"6175_CR5","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","volume":"128","author":"V Spina","year":"2016","unstructured":"Spina V et al (2016) The genetics of nodal marginal zone lymphoma. Blood 128(10):1362\u20131373","journal-title":"Blood"},{"issue":"2","key":"6175_CR6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1159\/000508704","volume":"13","author":"T Paul","year":"2020","unstructured":"Paul T et al (2020) Primary pleural extranodal marginal zone lymphoma presenting as bilateral Chylothorax. Case Rep Oncol 13(2):929\u2013934","journal-title":"Case Rep Oncol"},{"issue":"9","key":"6175_CR7","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1084\/jem.20120904","volume":"209","author":"D Rossi","year":"2012","unstructured":"Rossi D et al (2012) The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med 209(9):1537\u20131551","journal-title":"J Exp Med"},{"issue":"5","key":"6175_CR8","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/leu.2014.330","volume":"29","author":"A Clipson","year":"2015","unstructured":"Clipson A et al (2015) KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype. Leukemia 29(5):1177\u20131185","journal-title":"Leukemia"},{"issue":"2","key":"6175_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/leu.2014.294","volume":"29","author":"R Piva","year":"2015","unstructured":"Piva R et al (2015) The Kruppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. Leukemia 29(2):503\u2013507","journal-title":"Leukemia"},{"key":"6175_CR10","doi-asserted-by":"crossref","unstructured":"Clipson A et al (2015) mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype. Leukemia, 29(5): pp. 1177\u20131185","DOI":"10.1038\/leu.2014.330"},{"issue":"8","key":"6175_CR11","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.3324\/haematol.2016.161711","volume":"102","author":"Y Campos-Martin","year":"2017","unstructured":"Campos-Martin Y et al (2017) Clinical and diagnostic relevance of NOTCH2-and KLF2-mutations in splenic marginal zone lymphoma. Haematologica 102(8):e310\u2013e312","journal-title":"Haematologica"},{"issue":"10","key":"6175_CR12","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3324\/haematol.2016.160192","volume":"102","author":"L Jallades","year":"2017","unstructured":"Jallades L et al (2017) Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma. Haematologica 102(10):1758\u20131766","journal-title":"Haematologica"},{"issue":"3","key":"6175_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/ajh.25694","volume":"95","author":"L Qian","year":"2020","unstructured":"Qian L et al (2020) Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B-cell lymphoma. Am J Hematol 95(3):238\u2013244","journal-title":"Am J Hematol"},{"issue":"12","key":"6175_CR14","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1080\/02713683.2020.1762228","volume":"45","author":"D Jangam","year":"2020","unstructured":"Jangam D et al (2020) TBL1XR1 mutations in primary marginal zone lymphomas of Ocular Adnexa are Associated with Unique Morphometric Phenotypes. Curr Eye Res 45(12):1583\u20131589","journal-title":"Curr Eye Res"},{"key":"6175_CR15","doi-asserted-by":"crossref","unstructured":"Johansson P et al (2020) Identifying genetic lesions in ocular adnexal extranodal marginal zone lymphomas of the MALT subtype by whole genome, whole exome and targeted sequencing. Cancers (Basel), 12(4)","DOI":"10.3390\/cancers12040986"},{"issue":"3","key":"6175_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/hon.2718","volume":"38","author":"V Vela","year":"2020","unstructured":"Vela V et al (2020) High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. Hematol Oncol 38(3):284\u2013292","journal-title":"Hematol Oncol"},{"issue":"5","key":"6175_CR17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1182\/blood.2021012386","volume":"139","author":"F Bonfiglio","year":"2022","unstructured":"Bonfiglio F et al (2022) Genetic and phenotypic attributes of splenic marginal zone lymphoma. Blood 139(5):732\u2013747","journal-title":"Blood"},{"issue":"14","key":"6175_CR18","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1182\/bloodadvances.2022009415","volume":"7","author":"M Grau","year":"2023","unstructured":"Grau M et al (2023) Unraveling the genetics of transformed splenic marginal zone lymphoma. Blood Adv 7(14):3695\u20133709","journal-title":"Blood Adv"},{"issue":"10","key":"6175_CR19","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1084\/jem.20111855","volume":"208","author":"C Lobry","year":"2011","unstructured":"Lobry C, Oh P, Aifantis I (2011) Oncogenic and tumor suppressor functions of Notch in cancer: it\u2019s NOTCH what you think. J Exp Med 208(10):1931\u20131935","journal-title":"J Exp Med"},{"issue":"7247","key":"6175_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nature07969","volume":"459","author":"M Kato","year":"2009","unstructured":"Kato M et al (2009) Frequent inactivation of A20 in B-cell lymphomas. Nature 459(7247):712\u2013U118","journal-title":"Nature"},{"issue":"18","key":"6175_CR21","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1182\/blood-2011-06-359166","volume":"118","author":"D Rossi","year":"2011","unstructured":"Rossi D et al (2011) Alteration of BIRC3 and multiple other NF-kappaB pathway genes in splenic marginal zone lymphoma. Blood 118(18):4930\u20134934","journal-title":"Blood"},{"issue":"7332","key":"6175_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature09671","volume":"470","author":"VN Ngo","year":"2011","unstructured":"Ngo VN et al (2011) Oncogenically active MYD88 mutations in human lymphoma. Nature 470(7332):115\u2013119","journal-title":"Nature"},{"issue":"7247","key":"6175_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nature07968","volume":"459","author":"M Compagno","year":"2009","unstructured":"Compagno M et al (2009) Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 459(7247):717\u2013721","journal-title":"Nature"},{"issue":"2","key":"6175_CR24","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2141.1997.3973215.x","volume":"99","author":"L Baldini","year":"1997","unstructured":"Baldini L et al (1997) Poor prognosis in non-villous splenic marginal zone cell lymphoma is associated with p53 mutations. Br J Haematol 99(2):375\u2013378","journal-title":"Br J Haematol"},{"issue":"4","key":"6175_CR25","doi-asserted-by":"publisher","first-page":"e0174809","DOI":"10.1371\/journal.pone.0174809","volume":"12","author":"P Xu","year":"2017","unstructured":"Xu P et al (2017) TP53 mutation predicts the poor prognosis of non-hodgkin lymphomas: evidence from a meta-analysis. PLoS ONE 12(4):e0174809","journal-title":"PLoS ONE"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06175-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-06175-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06175-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T10:09:57Z","timestamp":1745575797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-06175-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6175"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-06175-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement and informed consent"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}